SOLVAY SA |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 33.65 EUR | -2.15% |
|
+11.65% | +21.35% |
| 05-07 | Transcript : Solvay SA, Q1 2024 Earnings Call, May 07, 2024 | |
| 05-07 | Solvay: lower underlying earnings in Q1 | CF |
ETFs positioned on Solvay SA
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 0 M€ | +3.63% | - | |
| 0.00% | 0 M€ | +2.80% | - | |
| 0.00% | 0 M€ | +2.72% | - | |
| 0.00% | 7 M€ | +0.11% | - | |
| 0.00% | 0 M€ | +0.50% | - | |
| 0.00% | 0 M€ | 0.00% | - | |
| 0.00% | 0 M€ | -2.25% | - | |
| 0.00% | 0 M€ | -2.58% | - | |
| 0.00% | 0 M€ | -3.22% | - |
Following the spinoff of its Specialty Chemicals business Syensqo in December 2023, Solvay SA is focused on providing chemical products and intermediates to customers in a broad range of consumer and industrial end-markets. Originally founded in 1863, Solvay's current portfolio is operated through five divisions: Soda Ash and Derivatives, Peroxides, Silica, Special Chem and Coatis. Solvay SA offers customer-proximate regional locations, large scale as well as competitive cost curve positioning due to the vertical integration in its main businesses, process technology and product know-how. The company has a balanced global footprint with 12 major R&I centres as well as 45 industrial sites in 41 countries across the world.
Sector
Diversified Chemicals
Calendar
2024-05-28
- Shareholders Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
HOLD
Number of Analysts
15
Last Close Price
33.65
EUR
Average target price
37.94
EUR
Spread / Average Target
+12.74%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +21.35% | 3.81B | |
| -1.96% | 74.28B | |
| +0.05% | 46.91B | |
| +2.38% | 32.93B | |
| +7.54% | 17.78B | |
| -6.58% | 12.09B | |
| +12.48% | 11.88B | |
| -0.23% | 10.66B | |
| +3.37% | 9.55B | |
| +5.01% | 8.28B |
- Stock Market
- Equities
- SOLB Stock
- Funds and ETFs Solvay SA
